Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-27 Purchase | 2025-05-27 3:24 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 10,000 | $2.11 | $21,100 | 6,480,825 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 7:37 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) | View |
| 2025-04-09 Sale | 2025-04-11 7:24 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) | View |
| 2025-04-07 Purchase | 2025-04-08 09:30 am | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Gen Counsel & Corporate Sec | 20,000 | $1.54 | $30,800 | 21,000 (Direct) | View |
| 2025-04-07 Purchase | 2025-04-08 09:25 am | Compass Therapeutics Inc. | CMPX | Lerner Neil CHIEF ACCOUNTING OFFICER | 20,000 | $1.42 | $28,400 | 320,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Shin Barry CFO | 670,000 | $0 | 1,195,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Shin Barry CFO | 125,000 | $5.17 | 1,195,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Sirard Cynthia Chief Medical Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO | 2,000,000 | $0 | 8,686,800 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO | 250,000 | $5.17 | 8,686,800 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Prasad Arjun Chief Commercial Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:33 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Lerner Neil Chief Accounting Officer | 435,000 | $0 | 817,500 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Lerner Neil Chief Accounting Officer | 62,500 | $5.17 | 817,500 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Boylan James P Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Ferneau Philip Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A 2036-01-02 | Compass Therapeutics Inc. | CMPX | Anderman Jonathan General Counsel | 720,000 | $0 | 891,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:32 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Anderman Jonathan General Counsel | 150,000 | $5.17 | 891,000 (Direct) | View |
| 2025-11-16 Tax Withholding | 2025-11-18 08:30 am | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 44,025 | $4.83 | 6,436,800 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:12 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Shin Barry CFO | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:12 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:11 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:11 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Lerner Neil SVP, CAO | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:10 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:10 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Ferneau Philip Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:09 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:09 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec | 280,000 | $0 | 280,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:08 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 5:05 pm | N/A 2035-02-11 | Compass Therapeutics Inc. | CMPX | Boylan James P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-02-08 Tax Withholding | 2025-02-11 10:37 am | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO | 41,687 | $3.5 | 6,470,825 (Direct) | View |
| 2025-01-09 Tax Withholding | 2025-01-13 08:30 am | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO | 58,054 | $1.86 | 6,512,512 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-10 2:02 pm | N/A 2034-12-09 | Compass Therapeutics Inc. | CMPX | Shin Barry CFO | 400,000 | $0 | 800,000 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-10 2:02 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Shin Barry CFO | 400,000 | $1.65 | 800,000 (Direct) | View |
Ownership | 2024-12-10 2:00 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Lerner Neil VP Finance | 0 | $0 | 880,000 (Direct) | View |
| 2024-08-13 Option Award | 2024-08-14 08:49 am | N/A 2034-08-13 | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2024-08-09 4:07 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec | 0 | $0 | 426,000 (Direct) | View |
| 2024-03-08 Option Award | 2024-03-11 10:12 am | N/A 2034-03-07 | Compass Therapeutics Inc. | CMPX | Boylan James P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:03 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:03 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director | 40,000 | $0 | 40,000 (Direct) | View |